Implementation of a new CSF dynamic device: a multicenter feasibility study in 562 patients

Malm J, Sundström N, Cesarini KG, Edsbagge M, Kristensen B, Leijon G, Eklund A. Implementation of a new CSF dynamic device: a multicenter feasibility study in 562 patients. 
Acta Neurol Scand: 2012: 125: 199–205. 
© 2011 John Wiley & Sons A/S. Objectives –  The cerebrospinal fluid (CSF) infusion...

Full description

Saved in:
Bibliographic Details
Published in:Acta neurologica Scandinavica Vol. 125; no. 3; pp. 199 - 205
Main Authors: Malm, J., Sundström, N., Cesarini, K. G., Edsbagge, M., Kristensen, B., Leijon, G., Eklund, A.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-03-2012
Blackwell
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malm J, Sundström N, Cesarini KG, Edsbagge M, Kristensen B, Leijon G, Eklund A. Implementation of a new CSF dynamic device: a multicenter feasibility study in 562 patients. 
Acta Neurol Scand: 2012: 125: 199–205. 
© 2011 John Wiley & Sons A/S. Objectives –  The cerebrospinal fluid (CSF) infusion test is frequently used when selecting hydrocephalus patients for shunt surgery. Very little has been reported regarding adverse events. We present a prospective feasibility study. Methods –  Standardized devices for measuring CSF dynamics were built and 562 patients investigated: Needles were placed by lumbar puncture (LP). An automatic CSF infusion protocol was performed. Course of events during the investigation as well as adverse events were registered. Results –  Preoperative evaluation of normal‐pressure hydrocephalus was the most common indication (63%), followed by evaluation of shunt function (23%) and intracranial pressure recordings (14%). The LP was successfully performed in all but nine cases with 24 patients (4.3%) reporting major discomfort. Ringer infusion was performed in 474 investigations, and a valid measurement of the outflow resistance was received in 439 (93%). During the infusion phase, 17 (4%) patients reported severe headache. Infusion volume was significantly higher in patients having subjective symptoms during the infusion phase compared with those without adverse events. During 269 preoperative CSF tap tests, six (2%) patients had severe headache. Post‐investigational headache was reported by 83 (15%) patients at the 24‐h follow‐up. No serious adverse events were observed. Conclusion –  Infusion testing was safe and without serious adverse events with a high rate of successful procedures. The investigation was associated with expected mild to moderate discomfort.
Bibliography:ArticleID:ANE1533
istex:752BDF24F4D66B496BB33033F9BF0899053BE203
ark:/67375/WNG-LGB9P2M1-X
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0001-6314
1600-0404
1600-0404
DOI:10.1111/j.1600-0404.2011.01533.x